IκB kinase ε-dependent phosphorylation and degradation of X-linked inhibitor of apoptosis sensitizes cells to virus-induced apoptosis

Journal of Virology

Volumn 86, Issue 2, 2012, Pages 726-737

  Nakhaei, Peyman ^a,b   Sun, Qiang ^a   Solis, Mayra ^a,b   Mesplede, Thibault ^a   Bonneil, Eric ^d   Paz, Suzanne ^a,b   Lin, Rongtuan ^a,b   Hiscotta, John ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Vaccine and Gene Therapy Institute of Florida   (United States)

^d INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; I KAPPA B KINASE EPSILON; INTERFERON REGULATORY FACTOR 3; PROTEIN BAX; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; SENDAI VIRUS; UBIQUITINATION;

AMINO ACID MOTIFS; APOPTOSIS; CELL LINE; HUMANS; I-KAPPA B KINASE; PHOSPHORYLATION; RESPIROVIRUS INFECTIONS; SENDAI VIRUS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

SENDAI VIRUS;

EID: 84856812315     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05989-11     Document Type: Article

References (69)

1. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
2. Barbie DA, et al. 2009. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462:108-112.
3. Belgnaoui SM, Paz S, Hiscott J. 2011. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr. Opin. Immunol. 23:564-572.
4. Besch R, et al. 2009. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J. Clin. Investig. 119:2399-2411.
5. Bodemann BO, White MA. 2008. Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat. Rev. Cancer 8:133-140.
6. Boehm JS, et al. 2007. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129:1065-1079.
7. Bozulic L, Hemmings BA. 2009. PIKKing on PKB: regulation of PKB activity by phosphorylation. Curr. Opin. Cell Biol. 21:256-261.
8. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R. 2003. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424:797-801.
9. Chattopadhyay S, et al. 2010. Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J. 29:1762-1773.
10. Chen ZJ. 2005. Ubiquitin signalling in the NF-kappaB pathway. Nat. Cell Biol. 7:758-765.
11. Chien Y, et al. 2006. RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 127:157-170.
12. Cummins JM, et al. 2004. X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosisinducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res. 64:3006-3008.
13. Dan HC, et al. 2004. Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J. Biol. Chem. 279:5405-5412.
14. Deveraux QL, Reed JC. 1999. IAP family proteins-suppressors of apoptosis. Genes Dev. 13:239-252.
15. Du C, Fang M, Li Y, Li L, Wang X. 2000. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33-42.
16. Eckelman BP, Salvesen GS, Scott FL. 2006. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 7:988-994.
17. Fitzgerald KA, et al. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-496.
18. Goubau D, et al. 2009. Transcriptional re-programming of primary macrophages reveals distinct apoptotic and anti-tumoral functions of IRF-3 and IRF-7. Eur. J. Immunol. 39:527-540.
19. Green DR, Kroemer G. 2004. The pathophysiology of mitochondrial cell death. Science 305:626-629.
20. Gyrd-Hansen M, et al. 2008. IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis. Nat. Cell Biol. 10:1309-1317.
21. Häcker H, et al. 2006. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439:204-207.
22. Heylbroeck C, et al. 2000. The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J. Virol. 74:3781-3792.
23. Hilleman MR. 2004. Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections. Proc. Natl. Acad. Sci. U. S. A. 101(Suppl. 2):14560-14566.
24. Hiscott J. 2004. Another detour on the Toll road to the interferon antiviral response. Nat. Struct. Mol. Biol. 11:1028-1030.
25. Hiscott J. 2007. Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18:483-490.
26. Hiscott J, Lin R, Nakhaei P, Paz S. 2006. MasterCARD: a priceless link to innate immunity. Trends Mol. Med. 12:53-56.
27. Honda K, Taniguchi T. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6:644-658.
28. Hornung V, et al. 2006. 5'-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997.
29. Hutti JE, et al. 2009. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. Mol. Cell 34:461-472.
30. Jacinto E, et al. 2006. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127:125-137.
31. Johnson CL, Gale M, Jr. 2006. CARD games between virus and host get a new player. Trends Immunol. 27:1-4.
32. Kato H, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
33. Kawai T, Akira S. 2007. Antiviral signaling through pattern recognition receptors. J. Biochem. 141:137-145.
34. Kawai T, Akira S. 2008. Toll-like receptor and RIG-I-like receptor signaling. Ann. N. Y. Acad. Sci. 1143:1-20.
35. Kawai T, et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988.
36. Korherr C, et al. 2006. Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway. Proc. Natl. Acad. Sci. U. S. A. 103:4240-4245.
37. Kovalenko A, et al. 2003. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424:801-805.
38. Kuranaga E, et al. 2006. Drosophila IKK-related kinase regulates nonapoptotic function of caspases via degradation of IAPs. Cell 126:583-596.
39. Lallemand C, et al. 2007. Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB. Oncogene 26:328-338.
40. Lei Y, et al. 2009. MAVS-mediated apoptosis and its inhibition by viral proteins. PLoS One 4:e5466.
41. Lin R, Genin P, Mamane Y, Hiscott J. 2000. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol. Cell. Biol. 20:6342-6353.
42. Lin R, et al. 2006. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J. Virol. 80:6072-6083.
43. Liston P, et al. 1996. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379:349-353.
44. Liu Z, et al. 2000. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature 408:1004-1008.
45. Loo YM, Gale M, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34:680-692.
46. Martins LM, et al. 2002. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J. Biol. Chem. 277: 439-444.
47. Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fassler R. 2006. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NFkappaB signaling. Cell 125:665-677.
48. Meylan E, et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172.
49. Nakhaei P, Genin P, Civas A, Hiscott J. 2009. RIG-I-like receptors: sensing and responding to RNA virus infection. Semin. Immunol. 21: 215-222.
50. Nakhaei P, et al. 2009. The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation. PLoS Pathog. 5:e1000650.
51. Oshima K, et al. 2006. IKK epsilon regulates F actin assembly and interacts with Drosophila IAP1 in cellular morphogenesis. Curr. Biol. 16: 1531-1537.
52. Ou YH, et al. 2011. TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. Mol. Cell 41:458-470.
53. Paz S, et al. 2006. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway. Cell Mol. Biol. 52:17-28.
54. Paz S, et al. 2009. Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter. Mol. Cell. Biol. 29: 3401-3412.
55. Paz S, et al. 2011. A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response. Cell Res. 21:895-910.
56. Peters K, Chattopadhyay S, Sen GC. 2008. IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence. J. Virol. 82:3500-3508.
57. Qin BY, et al. 2003. Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat. Struct. Biol. 10:913-921.
58. Salvesen GS, Duckett CS. 2002. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3:401-410.
59. Scott I, Norris KL. 2008. The mitochondrial antiviral signaling protein, MAVS, is cleaved during apoptosis. Biochem. Biophys. Res. Commun. 375:101-106.
60. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682.
61. Sharma S, et al. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151.
62. Srinivasula SM, et al. 2001. A conserved XIAP-interaction motif in caspase 9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410:112-116.
63. Takahasi K, et al. 2003. X-ray crystal structure of IRF-3 and its functional implications. Nat. Struct. Biol. 10:922-927.
64. Verhagen AM, et al. 2000. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102:43-53.
65. Verhagen AM, et al. 2002. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J. Biol. Chem. 277:445-454.
66. Vince JE, Tschopp J. 2010. IRF-3 partners Bax in a viral-induced dance macabre. EMBO J. 29:1627-1628.
67. Wang X. 2001. The expanding role of mitochondria in apoptosis. Genes Dev. 15:2922-2933.
68. White CL, Chattopadhyay S, Sen GC. 2011. Phosphatidylinositol 3-kinase signaling delays sendai virus-induced apoptosis by preventing XIAP degradation. J. Virol. 85:5224-5227.
69. Xu LG, et al. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19:727-740.